Cargando…

Advances in dyslipidemia /

In eight expertly authored chapters, Advances in Dyslipidemia provides an excellent overview for any physician taking care of patients with atherosclerotic vascular disease or at high-risk or moderate-risk for atherosclerotic vascular disease.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Aronow, Wilbert S. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London : Future Medicine Ltd, 2013, ©2013.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mi 4500
001 EBOOKCENTRAL_ocn953863220
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |||||||||||
008 160212s2013 enk o 000 0 eng d
040 |a NLE  |b eng  |e rda  |e pn  |c NLE  |d EBLCP  |d MERUC  |d ZCU  |d ICG  |d USU  |d OCLCO  |d OCLCQ  |d OCLCO  |d VT2  |d AU@  |d OCLCO  |d OCLCF  |d OCLCQ  |d WYU  |d OCLCO  |d OCLCA  |d TKN  |d DKC  |d OCLCO  |d OCLCQ  |d OCLCA  |d YDX  |d TEF  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
019 |a 1006298867 
020 |a 9781780843308  |q (Electronic book) 
020 |a 1780843305 
020 |a 1780843313  |q (electronic bk.) 
020 |a 9781780843315  |q (electronic bk.) 
020 |z 9781780843322 
020 |z 1780843321 
035 |a (OCoLC)953863220  |z (OCoLC)1006298867 
037 |a 10.2217/9781780843308  |b Future Science 
050 4 |a RC632.L5  |b .A383 2014 
060 4 |a WD 200.5.H8 
082 0 4 |a 616.3997  |2 23 
049 |a UAMI 
245 0 0 |a Advances in dyslipidemia /  |c editor Wilbert S. Aronow. 
264 1 |a London :  |b Future Medicine Ltd,  |c 2013, ©2013. 
300 |a 1 online resource (125 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a Advances in dyslipidemia -- Atherosclerosis: dyslipidemia, inflammation and lipoapoptosis -- Familial hypercholesterolemia: bridging and minding the gap in healthcare -- PCSK9 inhibition: drug development for low-density lipoprotein lowering -- Novel therapies for dyslipidemia -- The highs and lows of high-density lipoportein -- Do we need to treat patients with heart failure with statins? -- Management of dyslipidemia in patients with nonalcoholic fatty liver disease -- Dyslipidemia: current management and the challenge of residual cardiovascular risk reduction. 
520 |a In eight expertly authored chapters, Advances in Dyslipidemia provides an excellent overview for any physician taking care of patients with atherosclerotic vascular disease or at high-risk or moderate-risk for atherosclerotic vascular disease. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Lipids  |x Metabolism  |x Disorders. 
650 0 |a Blood cholesterol. 
650 0 |a Blood lipids. 
650 2 |a Dyslipidemias 
650 6 |a Cholestérolémie. 
650 6 |a Lipides plasmatiques. 
650 7 |a Blood cholesterol  |2 fast 
650 7 |a Blood lipids  |2 fast 
650 7 |a Lipids  |x Metabolism  |x Disorders  |2 fast 
700 1 |a Aronow, Wilbert S.,  |e editor. 
758 |i has work:  |a Advances in dyslipidemia (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFtftRHVrXQQJkp7vQvtBq  |4 https://id.oclc.org/worldcat/ontology/hasWork 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5092476  |z Texto completo 
938 |a EBL - Ebook Library  |b EBLB  |n EBL5092476 
938 |a YBP Library Services  |b YANK  |n 14880238 
994 |a 92  |b IZTAP